Pesquisa | Biblioteca Virtual em Saúde

1.

Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label study.

Lebwohl, M G; Stein Gold, L; Papp, K; Han, G; Pariser, D M; Lin, T; Harris, S; Jacobson, A.

J Eur Acad Dermatol Venereol ; 35(5): 1152-1160, 2021 May.

Artigo em Inglês | MEDLINE | ID: mdl-33428282

2.

Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled study.

Schmieder, G J; Draelos, Z D; Pariser, D M; Banfield, C; Cox, L; Hodge, M; Kieras, E; Parsons-Rich, D; Menon, S; Salganik, M; Page, K; Peeva, E.

Br J Dermatol ; 179(1): 54-62, 2018 07.

Artigo em Inglês | MEDLINE | ID: mdl-28949012

3.

Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study.

Bissonnette, R; Haydey, R; Rosoph, L A; Lynde, C W; Bukhalo, M; Fowler, J F; Delorme, I; Gagné-Henley, A; Gooderham, M; Poulin, Y; Barber, K; Jenkin, P; Landells, I; Pariser, D M.

J Eur Acad Dermatol Venereol ; 32(3): 403-410, 2018 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-29055155

4.

Pioneers in Dermatology and Venereology: an Interview with Professor David M. Pariser.

Pariser, D M.

J Eur Acad Dermatol Venereol ; 36(4): 496-498, 2022 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-35289440

5.

Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.

Pariser, D M; Eichenfield, L F; Bukhalo, M; Waterman, G; Jarratt, M.

Br J Dermatol ; 174(4): 770-7, 2016 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-26663215

6.

Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Menter, A; Papp, K A; Gooderham, M; Pariser, D M; Augustin, M; Kerdel, F A; Fakharzadeh, S; Goyal, K; Calabro, S; Langholff, W; Chavers, S; Naessens, D; Sermon, J; Krueger, G G.

J Eur Acad Dermatol Venereol ; 30(7): 1148-58, 2016 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-27027388

7.

Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version.

Werner, R N; Stockfleth, E; Connolly, S M; Correia, O; Erdmann, R; Foley, P; Gupta, A K; Jacobs, A; Kerl, H; Lim, H W; Martin, G; Paquet, M; Pariser, D M; Rosumeck, S; Röwert-Huber, H-J; Sahota, A; Sangueza, O P; Shumack, S; Sporbeck, B; Swanson, N A; Torezan, L; Nast, A.

J Eur Acad Dermatol Venereol ; 29(11): 2069-79, 2015 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-26370093

8.

Incidence of serious gastrointestinal events among tildrakizumab-treated patients with psoriasis: Letter to the Editor.

Gooderham, M; Elewski, B E; Pariser, D M; Sofen, H; Mendelsohn, A M; Rozzo, S J; Li, Q.

J Eur Acad Dermatol Venereol ; 33(10): e350-e352, 2019 10.

Artigo em Inglês | MEDLINE | ID: mdl-31033068

9.

Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.

Leung, D Y M; Hanifin, J M; Pariser, D M; Barber, K A; Langley, R G; Schlievert, P M; Abrams, B; Hultsch, T.

Br J Dermatol ; 161(2): 435-43, 2009 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-19416245

10.

Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity.

Nelson, L M; DiBenedetti, D; Pariser, D M; Glaser, D A; Hebert, A A; Hofland, H; Drew, J; Ingolia, D; Gillard, K K; Fehnel, S.

J Patient Rep Outcomes ; 3(1): 59, 2019 Sep 05.

Artigo em Inglês | MEDLINE | ID: mdl-31486951

11.

A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.

Guenther, L C; Poulin, Y P; Pariser, D M.

Clin Ther ; 22(10): 1225-38, 2000 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-11110233

12.

Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis.

Katz, H I; Lindholm, J S; Weiss, J S; Shavin, J S; Morman, M; Bressinck, R; Cornell, R; Pariser, D M; Pariser, R J; Weng, W.

Clin Ther ; 17(3): 390-401, 1995.

Artigo em Inglês | MEDLINE | ID: mdl-7585843

13.

Mycosis fungoides involving the brain and optic nerves.

Pariser, D M.

Arch Dermatol ; 114(3): 397-9, 1978 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-629577

14.

Quinidine photosensitivity.

Pariser, D M; Taylor, J R.

Arch Dermatol ; 111(11): 1440-3, 1975 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-128321

15.

Intravenous desensitization to mechlorethamine in patients with psoriasis.

Pariser, D M; Childers, R C; Kechijian, P; Halprin, K M; Taylor, J R.

Arch Dermatol ; 112(8): 1113-4, 1976 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-952529

16.

Topical steroids: a guide for use in the elderly patient.

Pariser, D M.

Geriatrics ; 46(10): 51-4, 57-60, 63, 1991 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-1916302

17.

Basal cell carcinoma: when to treat it yourself, and when to refer.

Pariser, D M; Phillips, P K.

Geriatrics ; 49(3): 39-44, 1994 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-8125351

18.

Oxiconazole nitrate lotion, 1 percent: an effective treatment for tinea pedis.

Pariser, D M; Pariser, R J.

Cutis ; 54(1): 43-4, 1994 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-7924451

19.

Cosmetic procedures we all perform.

Phillips, P K; Pariser, D M; Pariser, R J.

Cutis ; 53(4): 187-91, 1994 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-8200225

20.

Cutaneous viral infections: herpes simplex and varicella-zoster.

Pariser, D M.

Prim Care ; 16(3): 577-89, 1989 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-2678171

Biblioteca Virtual em Saúde

Saúde Pública Brasil

Sua seleção (0)

Formato de exportação:

Exportar:

Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label study.

Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled study.

Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study.

Pioneers in Dermatology and Venereology: an Interview with Professor David M. Pariser.

Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.

Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version.

Incidence of serious gastrointestinal events among tildrakizumab-treated patients with psoriasis: Letter to the Editor.

Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.

Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity.

A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.

Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis.

Mycosis fungoides involving the brain and optic nerves.

Quinidine photosensitivity.

Intravenous desensitization to mechlorethamine in patients with psoriasis.

Topical steroids: a guide for use in the elderly patient.

Basal cell carcinoma: when to treat it yourself, and when to refer.

Oxiconazole nitrate lotion, 1 percent: an effective treatment for tinea pedis.

Cosmetic procedures we all perform.

Cutaneous viral infections: herpes simplex and varicella-zoster.